Ameriprise Financial Inc Editas Medicine, Inc. Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 59,475 shares of EDIT stock, worth $77,912. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59,475
Previous 37,709 57.72%
Holding current value
$77,912
Previous $176,000 14.77%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.39 - $5.96 $73,786 - $129,725
21,766 Added 57.72%
59,475 $202,000
Q2 2024

Aug 14, 2024
BUY
$4.67 - $7.28 $27,707 - $43,192
5,933 Added 18.67%
37,709 $176,000
Q1 2024

May 15, 2024
SELL
$7.03 - $11.07 $47,058 - $74,102
-6,694 Reduced 17.4%
31,776 $235,000
Q4 2023

Feb 14, 2024
BUY
$6.25 - $11.11 $157,837 - $280,571
25,254 Added 191.09%
38,470 $389,000
Q3 2023

Nov 14, 2023
SELL
$6.92 - $9.31 $41,755 - $56,176
-6,034 Reduced 31.35%
13,216 $103,000
Q2 2023

Aug 14, 2023
SELL
$6.36 - $11.47 $249,566 - $450,082
-39,240 Reduced 67.09%
19,250 $158,000
Q1 2023

May 15, 2023
SELL
$7.03 - $11.53 $954,456 - $1.57 Million
-135,769 Reduced 69.89%
58,490 $424,000
Q4 2022

Feb 14, 2023
SELL
$8.32 - $13.21 $52,208 - $82,892
-6,275 Reduced 3.13%
194,259 $1.72 Million
Q3 2022

Nov 14, 2022
BUY
$12.16 - $19.42 $1.88 Million - $3.01 Million
154,906 Added 339.5%
200,534 $2.45 Million
Q2 2022

Aug 15, 2022
SELL
$9.99 - $21.35 $15,864 - $33,903
-1,588 Reduced 3.36%
45,628 $539,000
Q1 2022

May 16, 2022
SELL
$14.08 - $27.63 $74,581 - $146,356
-5,297 Reduced 10.09%
47,216 $898,000
Q4 2021

Feb 14, 2022
BUY
$26.55 - $40.57 $455,173 - $695,532
17,144 Added 48.47%
52,513 $1.4 Million
Q3 2021

Nov 15, 2021
SELL
$39.27 - $72.94 $544,360 - $1.01 Million
-13,862 Reduced 28.16%
35,369 $1.45 Million
Q2 2021

Aug 16, 2021
BUY
$31.29 - $56.64 $383,271 - $693,783
12,249 Added 33.12%
49,231 $2.79 Million
Q1 2021

May 17, 2021
BUY
$39.71 - $90.58 $462,184 - $1.05 Million
11,639 Added 45.93%
36,982 $1.55 Million
Q4 2020

Feb 12, 2021
BUY
$27.07 - $84.35 $386,938 - $1.21 Million
14,294 Added 129.37%
25,343 $1.67 Million
Q3 2020

Nov 16, 2020
SELL
$28.06 - $37.16 $84,460 - $111,851
-3,010 Reduced 21.41%
11,049 $309,000
Q2 2020

Aug 14, 2020
SELL
$18.5 - $34.34 $153,957 - $285,777
-8,322 Reduced 37.18%
14,059 $414,000
Q1 2020

May 15, 2020
SELL
$14.88 - $32.78 $440,834 - $971,140
-29,626 Reduced 56.97%
22,381 $444,000
Q4 2019

Feb 14, 2020
SELL
$19.49 - $32.63 $372,434 - $623,526
-19,109 Reduced 26.87%
52,007 $1.54 Million
Q3 2019

Nov 14, 2019
BUY
$22.49 - $26.81 $394,069 - $469,764
17,522 Added 32.69%
71,116 $1.62 Million
Q2 2019

Aug 14, 2019
SELL
$20.48 - $27.76 $227,614 - $308,524
-11,114 Reduced 17.18%
53,594 $1.33 Million
Q1 2019

May 15, 2019
BUY
$19.43 - $26.41 $308,256 - $418,994
15,865 Added 32.48%
64,708 $1.58 Million
Q4 2018

Feb 14, 2019
SELL
$18.19 - $31.79 $105,993 - $185,240
-5,827 Reduced 10.66%
48,843 $1.11 Million
Q3 2018

Nov 14, 2018
BUY
$27.65 - $38.39 $583,332 - $809,913
21,097 Added 62.84%
54,670 $1.74 Million
Q2 2018

Aug 14, 2018
BUY
$31.4 - $41.01 $432,346 - $564,666
13,769 Added 69.53%
33,573 $1.2 Million
Q1 2018

May 15, 2018
BUY
$29.84 - $44.08 $590,951 - $872,960
19,804 New
19,804 $580,000

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email